These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 28472755)
1. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells. Zhang J; Kong R; Sun L Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755 [TBL] [Abstract][Full Text] [Related]
2. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway. Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related]
4. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer. Zhang H; Zhao JH; Suo ZM Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137 [TBL] [Abstract][Full Text] [Related]
6. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138 [TBL] [Abstract][Full Text] [Related]
7. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728 [TBL] [Abstract][Full Text] [Related]
8. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
9. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells. Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873 [TBL] [Abstract][Full Text] [Related]
11. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Zhu L; Wang Z; Fan Q; Wang R; Sun Y Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848 [TBL] [Abstract][Full Text] [Related]
12. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway. Zhang GJ; Zhao J; Jiang ML; Zhang LC Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway. Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164 [TBL] [Abstract][Full Text] [Related]
14. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription. Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985 [TBL] [Abstract][Full Text] [Related]
15. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
17. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells. Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489 [TBL] [Abstract][Full Text] [Related]
18. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315 [TBL] [Abstract][Full Text] [Related]
19. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway. Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170 [TBL] [Abstract][Full Text] [Related]
20. COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway. Hu J; Li P; Dan Y; Chen Z; Lu Y; Chen X; Yan S Ann Surg Oncol; 2024 May; 31(5):3502-3512. PubMed ID: 38429534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]